185
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 741-755 | Published online: 04 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tingjian Yan, Mallik Greene, Eunice Chang, Christy R Houle, Marian H Tarbox & Michael S Broder. (2020) Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder. ClinicoEconomics and Outcomes Research 12, pages 81-89.
Read now

Articles from other publishers (1)

. (2019) Adjunctive brexpiprazole in major depression: lower medical costs. PharmacoEconomics & Outcomes News 843:1, pages 4-4.
Crossref